International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Page 68 , April 2010

Author response: Diphenylhydantoin and insulinoma

Received 5 December 2009 ,Accepted 5 December 2009.

References 

  1. Levin SR, Grodsky GM, Hagura R, et al. Comparison of the inhibitory effects of diphenylhydantoin and diazoxide upon insulin secretion from the isolated perfused pancreas. Diabetes. 1972;21:856–862
  2. Kizer JS, Vargas-Cordon M, Brendel K, et al. The in vitro inhibition of insulin secretion by diphenylhydantoin. J Clin Invest. 1970;49(10):1942–1948
  3. Cohen MS, Bower RH, Fidler SM, et al. Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma. Lancet. 1973;301(7793):40–41
  4. Imanaka S, Matsuda S, Ito K, et al. Medical treatment for inoperable Insulinoma: clinical usefulness of diphenylhydantoin and diltiazem. Jpn J Clin Oncol. 1986;16:65–71

PII: S1877-5934(09)00061-7

doi: 10.1016/j.ijdm.2009.12.004

International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Page 68 , April 2010

Article Tools